Journal article

34 ORAL Advantages of a modified continual reassessment method (CRM) for dose finding studies: experience in ongoing phase I trials with ABT-263

Y Chiu, CM Rudin, GI Shapiro, AW Roberts, JR Brown, W Wilson, O O'Connor, H Xiong, S Enschede, A Krivoshik

European Journal of Cancer Supplements | Elsevier BV | Published : 2008

University of Melbourne Researchers